OPEN Foundation

Day: 1 May 2017

Monoamine Oxidase Inhibitors—Revisiting a Therapeutic Principle

Abstract

Over more than 60 years, monoamine oxidase (MAO) inhibitors are available for therapy of central nervous diseases. Although they have shown to be efficacious specifically in the treatment of major depressive disorders and treatment-resistant depression, they became less a therapeutic choice for the physicians mostly due to severe side effects, such as liver failure and hypertensive crisis associated specifically with the first generation of inhibitors. Nevertheless, this class of drugs is still being used for treatment specifically as more selective and reversible inhibitors became available and will provide clinicians with additional treatment options. The current review revisits monoamine oxidase inhibitors and their potential in the treatment of human diseases, such as anxiety, depression, mood and personality disorders, and pain and introduces current ideas and developments.
Entzeroth, M., & Ratty, A. K. (2017). Monoamine Oxidase Inhibitors—Revisiting a Therapeutic Principle. Open Journal of Depression6(02), 31. 10.4236/ojd.2017.62004
Link to full text

Growing Evidence for Heterogeneous Synaptic Localization of 5-HT2A Receptors

Abstract

The serotonin 2A (5-HT2A) receptor subtype continues to attract attention as a target for numerous psychoactive drugs including psychedelic hallucinogens, antidepressants, anxiolytics, and atypical antipsychotics. 5-HT2A receptors are a principal G protein-coupled receptor subtype mediating the excitatory effects of serotonin. Nonetheless, pre- vs postsynaptic localization of 5HT2A receptors, relative to glutamatergic synapses, has remained controversial. Here, we discuss recent findings highlighting the existence and roles of presynaptic 5-HT2A receptors in regulating glutamatergic transmission and cognition.

Bécamel, C., Berthoux, C., Barre, A., & Marin, P. (2017). Growing Evidence for Heterogeneous Synaptic Localization of 5-HT2A Receptors. 10.1021/acschemneuro.6b00409
Link to full text

"Too Hot to Handle": LSD, Medical Activism, and the Spring Grove Studies

Abstract

In the early 1950s, medical researchers across the United States began investigating the use of the hallucinogenic drug lysergic acid diethylamide (LSD) as a facilitating agent in psychotherapy. Despite great promise, crisis struck this young field when, in the early 1960s, the federal government began tightening regulations on LSD—this being a result of public and political anxieties about increasing recreational use of the drug, as well as changing clinical trial standards. Scholars maintain that psychedelic researchers unilaterally responded to the crisis by abandoning the field, fearing that their continued association with the drug would wreak havoc on their careers and personal lives. However, a close examination of the proceedings at the Spring Grove State Hospital, located in Catonsville, Maryland, tells a different story. Drawing on archival material from Purdue’s Psychoactive Substances Research Collection, this thesis explores the Spring Grove research team’s effort to midwife a more favorable view of this defamed drug. In doing so, this analysis provides a new perspective on psychedelic researchers’ response to the LSD crisis.
Haslem, L. N. (2017). ” Too Hot to Handle”: LSD, Medical Activism, and the Spring Grove Studies.
Link to full text

“Too Hot to Handle”: LSD, Medical Activism, and the Spring Grove Studies

Abstract

In the early 1950s, medical researchers across the United States began investigating the use of the hallucinogenic drug lysergic acid diethylamide (LSD) as a facilitating agent in psychotherapy. Despite great promise, crisis struck this young field when, in the early 1960s, the federal government began tightening regulations on LSD—this being a result of public and political anxieties about increasing recreational use of the drug, as well as changing clinical trial standards. Scholars maintain that psychedelic researchers unilaterally responded to the crisis by abandoning the field, fearing that their continued association with the drug would wreak havoc on their careers and personal lives. However, a close examination of the proceedings at the Spring Grove State Hospital, located in Catonsville, Maryland, tells a different story. Drawing on archival material from Purdue’s Psychoactive Substances Research Collection, this thesis explores the Spring Grove research team’s effort to midwife a more favorable view of this defamed drug. In doing so, this analysis provides a new perspective on psychedelic researchers’ response to the LSD crisis.
Haslem, L. N. (2017). ” Too Hot to Handle”: LSD, Medical Activism, and the Spring Grove Studies.
Link to full text

interested in becoming a trained psychedelic-assisted therapist?

Q&A with Rachel Harris: Wisdom from the Psychedelic Underground - Online Event - Oct 16th